Effects of bound versus soluble pentosan polysulphate in PEG/HA-based hydrogels tailored for intervertebral disc regeneration.

Previous reports in the literature investigating chondrogenesis in mesenchymal progenitor cell (MPC) cultures have confirmed the chondro-inductive potential of pentosan polysulphate (PPS), a highly sulphated semi-synthetic polysaccharide, when added as a soluble component to culture media under standard aggregate-assay conditions or to poly(ethylene glycol)/hyaluronic acid (PEG/HA)-based hydrogels, even in the absence of inductive factors (e.g. TGFβ). In this present study, we aimed to assess whether a 'bound' PPS would have greater activity and availability over a soluble PPS, as a media additive or when incorporated into PEG/HA-based hydrogels. We achieved this by covalently pre-binding the PPS to the HA component of the gel (forming a new molecule, HA-PPS). We firstly investigated the activity of HA-PPS compared to free PPS, when added as a soluble factor to culture media. Cell proliferation, as determined by CCK8 and EdU assay, was decreased in the presence of either bound or free PPS whilst chondrogenic differentiation, as determined by DMMB assay and histology, was enhanced. In all cases, the effect of the bound PPS (HA-PPS) was more potent than that of the unbound form. These results alone suggest wider applications for this new molecule, either as a culture supplement or as a coating for scaffolds targeted at chondrogenic differentiation or maturation. We then investigated the incorporation of HA-PPS into a PEG/HA-based hydrogel system, by simply substituting some of the HA for HA-PPS. Rheological testing confirmed that incorporation of either HA-PPS or PPS did not significantly affect gelation kinetics, final hydrogel modulus or degradation rate but had a small, but significant, effect on swelling. When encapsulated in the hydrogels, MPCs retained good viability and rapidly adopted a rounded morphology. Histological analysis of both GAG and collagen deposition after 21 days showed that the incorporation of the bound-PPS into the hydrogel resulted in increased matrix formation when compared to the addition of soluble PPS to the hydrogel, or the hydrogel alone. We believe that this new generation injectable, degradable hydrogel, incorporating now a covalently bound-PPS, when combined with MPCs, has the potential to assist cartilage regeneration in a multitude of therapeutic targets, including for intervertebral disc (IVD) degeneration.

[1]  B. Uygun,et al.  Effects of immobilized glycosaminoglycans on the proliferation and differentiation of mesenchymal stem cells. , 2009, Tissue engineering. Part A.

[2]  B. Vernon‐roberts,et al.  Immunoselected STRO-3 + mesenchymal precursor cells and restoration of the extracellular matrix of degenerate intervertebral discs Laboratory investigation , 2012 .

[3]  K. Anseth,et al.  The effect of heparin-functionalized PEG hydrogels on three-dimensional human mesenchymal stem cell osteogenic differentiation. , 2007, Biomaterials.

[4]  S. Seif-Naraghi,et al.  Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor. , 2012, Acta Biomaterialia.

[5]  P. Ghosh Seminars in Arthritis and Rheumatism , 1999 .

[6]  Adam J. Engler,et al.  Matrix elasticity directs stem cell differentiation , 2006 .

[7]  Aniq B. Darr,et al.  Synthesis and characterization of tyramine-based hyaluronan hydrogels , 2009, Journal of materials science. Materials in medicine.

[8]  R. Przygodzki,et al.  A novel role of fibroblast growth factor-2 and pentosan polysulfate in the pathogenesis of intestinal bleeding in mice. , 2007, American journal of physiology. Heart and circulatory physiology.

[9]  Justin J Cooper-White,et al.  An injectable hydrogel incorporating mesenchymal precursor cells and pentosan polysulphate for intervertebral disc regeneration. , 2013, Biomaterials.

[10]  Justin Cooper-White,et al.  The influence of substrate creep on mesenchymal stem cell behaviour and phenotype. , 2011, Biomaterials.

[11]  A. Gefen,et al.  In situ forming hydrogels composed of oxidized high molecular weight hyaluronic acid and gelatin for nucleus pulposus regeneration. , 2013, Acta biomaterialia.

[12]  A. Badke,et al.  Rheological and biological properties of a hydrogel support for cells intended for intervertebral disc repair , 2012, BMC Musculoskeletal Disorders.

[13]  G. Stein,et al.  Heparan sulfate enhances the self-renewal and therapeutic potential of mesenchymal stem cells from human adult bone marrow. , 2012, Stem cells and development.

[14]  S. Gronthos,et al.  Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow , 2003, Journal of Cell Science.

[15]  Dongan Wang,et al.  A mixed co‐culture of mesenchymal stem cells and transgenic chondrocytes in alginate hydrogel for cartilage tissue engineering , 2015, Journal of tissue engineering and regenerative medicine.

[16]  Kristi S Anseth,et al.  Dexamethasone-functionalized gels induce osteogenic differentiation of encapsulated hMSCs. , 2006, Journal of biomedical materials research. Part A.

[17]  Abhijeet Joshi,et al.  Functional compressive mechanics of a PVA/PVP nucleus pulposus replacement. , 2006, Biomaterials.

[18]  K. Anseth,et al.  Extracellular matrix protein adsorption to phosphate-functionalized gels from serum promotes osteogenic differentiation of human mesenchymal stem cells. , 2013, Acta biomaterialia.

[19]  Mary Murphy,et al.  Type II collagen-hyaluronan hydrogel--a step towards a scaffold for intervertebral disc tissue engineering. , 2010, European cells & materials.

[20]  Jussi Taipale,et al.  Growth factors in the extracellular matrix , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  Pawan Kumar Gupta,et al.  Glycosaminoglycans enhance osteoblast differentiation of bone marrow derived human mesenchymal stem cells , 2014, Journal of tissue engineering and regenerative medicine.

[22]  S. Gronthos,et al.  Pentosan polysulfate promotes proliferation and chondrogenic differentiation of adult human bone marrow-derived mesenchymal precursor cells , 2010, Arthritis research & therapy.

[23]  F. O'Brien,et al.  Mesenchymal stem cell fate is regulated by the composition and mechanical properties of collagen-glycosaminoglycan scaffolds. , 2012, Journal of the mechanical behavior of biomedical materials.

[24]  A. Zannettino,et al.  A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cells. , 2007, Stem cells and development.

[25]  C. Vignes-Colombeix,et al.  Pharmacological Modulation of Human Mesenchymal Stem Cell Chondrogenesis by a Chemically Oversulfated Polysaccharide of Marine Origin: Potential Application to Cartilage Regenerative Medicine , 2011, Stem cells.

[26]  J. S. Park,et al.  Chondrogenic differentiation of mesenchymal stem cells embedded in a scaffold by long-term release of TGF-beta 3 complexed with chondroitin sulfate. , 2009, Journal of biomedical materials research. Part A.

[27]  L. Liou,et al.  Sodium pentosan polysulfate reduces urothelial responses to inflammatory stimuli via an indirect mechanism. , 2002, The Journal of urology.

[28]  G. Vunjak‐Novakovic,et al.  Hybrid Gel Composed of Native Heart Matrix and Collagen Induces Cardiac Differentiation of Human Embryonic Stem Cells without Supplemental Growth Factors , 2011, Journal of cardiovascular translational research.

[29]  S. Gronthos,et al.  Perivascular Niche of Postnatal Mesenchymal Stem Cells in Human Bone Marrow and Dental Pulp , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  S. Sen,et al.  Matrix Elasticity Directs Stem Cell Lineage Specification , 2006, Cell.

[31]  A. Lowman,et al.  Synthesis and characterization of injectable bioadhesive hydrogels for nucleus pulposus replacement and repair of the damaged intervertebral disc. , 2010, Journal of biomedical materials research. Part B, Applied biomaterials.

[32]  Jun Wu,et al.  Infarct stabilization and cardiac repair with a VEGF-conjugated, injectable hydrogel. , 2011, Biomaterials.